Aclaris Therapeutics (ACRS) announced that Jesse Hall, M.D. has been appointed as Chief Medical Officer. Dr. Hall’s extensive medical and clinical development experience in areas including immunology and antibody development will be essential as he leads Aclaris’ clinical strategy to leverage the opportunities in the Company’s portfolio of immuno-inflammatory product candidates.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACRS:
- Aclaris Therapeutics: Promising Pipeline and Strategic Developments Justify Buy Rating
- Aclaris Therapeutics’ IND for ATI-052 candidate granted FDA clearance
- Aclaris Therapeutics assumed with an Overweight at Cantor Fitzgerald
- Tesla upgraded, Coinbase initiated: Wall Street’s top analyst calls
- Aclaris Therapeutics initiated with an Outperform at Scotiabank